Balaji, M.S. and Girish, M. 2022. A study of utility of delta IgG as a prognostic marker in Guillain Barre Syndrome after IV immunoglobulin treatment. International journal of health sciences. 6, S5 (Jun. 2022), 4274–4287. DOI:https://doi.org/10.53730/ijhs.v6nS5.9555.